Jennifer Ross is the co-founder and co-CEO of Swoon, the zero-sugar beverage brand reinventing the classics, like lemonade and iced tea. She co-founded the brand alongside her friend and former Harvard Business School classmate, Cristina Ros Blankfein.

Jennifer was diagnosed with Type 1 Diabetes at the age of 6 and has long been an advocate for the advancement of diabetes research. While still in high school, she founded and organized Rock the Cure, a concert to benefit Breakthrough T1D (formerly JDRF), which raised over $200,000. Now, she’s tackling sweetened beverages, knowing they’re the #1 source of added sugar. With Jennifer at the helm, Swoon is on track to eliminate one billion grams of sugar from the supply chain.

Prior to receiving her M.B.A, Jennifer worked on marketing and operations at Fanvision, and previously served as an Analyst at Goldman Sachs in the Merchant Bank’s Real Estate Group. She holds a B.A. in Government from Dartmouth College and an M.B.A from Harvard Business School.

Chief Investment Officer, Chevy Chase Trust

 

Amy Raskin is a pioneer in global thematic investing and widely respected as a bold thought leader. As the Chief Investment Officer of Chevy Chase Trust since February 1, 2014, she has propelled the firm to a leadership position in thematic investing, a small, but rapidly growing approach to investing that MSCI  added to its universe of style categories last year.

 

Under her leadership, Chevy Chase Trust has outperformed its global benchmark in each of the last seven years, by an average of 5.5% after fees; it is in the top decile of managers for the last 3-, 5- and 10 years. Amy is also a monthly guest on CNBC.

 

Prior to joining Chevy Chase Trust, Amy was Senior Vice President at AllianceBernstein in New York, serving as Director of Research for Thematic Portfolios, Director of Research on Strategic Change, head of U.S. & Global Growth Equity Research and Chief Investment Officer of AB Venture Capital Fund. The Research on Strategic Change team published in-depth research papers on a wide range of thematic investment topics, such as broadband, China, hybrid vehicles, climate change and molecular medicine.

Earlier, she worked as an investment banker at Lehman Brothers and as a research analyst at Donaldson, Lufkin & Jenrette.

 

Amy graduated from the University of Pennsylvania’s School of Engineering and Applied Science with a Bachelor of Science in Engineering and is an active, long-term member of the Penn Association of Alumnae and the Trustees’ Council of Penn Women (TCPW). She currently serves as Co-Chair of the TCPW Development Committee, and sits on the School of Engineering and Applied Science’s Technical Advisory Board. Her most recent commitment is to funding and supporting research on Type 1 diabetes, which her younger son was diagnosed with in mid-2020.